✦ LIBER ✦

EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer

✍ Scribed by A. Hamilton; J.-A. Roy; L. Beex; M. Piccart; L. Mauriac; R. Coleman; R. Paridaens; G. Hoctin Boes; A. van Vreckem; P. Palmer; J. Klijn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of sorafenib with anast

✍ Claudine Isaacs; Pia Herbolsheimer; Minetta C. Liu; Mary Wilkinson; Yvonne Ottav 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 220 KB

Results of a phase II study of pemetrexe

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

Phase II study of ifosfamide plus vinore

✍ F. Lobo; A. Frau; A. Barnadas; M. Méndez; J. Lizón; M. Provencio; J. J. Albistur 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 73 KB

A phase II study of pemetrexed and carbo

✍ August Garin; Alexey Manikhas; Mikhail Biakhov; Mikhail Chezhin; Tatiana Ivanche 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

A Cancer Research (UK) randomized phase

✍ S.R.D. Johnston; L.A. Gumbrell; T.R.J. Evans; R.E. Coleman; I.E. Smith; C.J. Twe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 238 KB

Phase II study of capecitabine and trast

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB